Additional file 7: of SUMO1 modification of KHSRP regulates tumorigenesis by preventing the TL-G-Rich miRNA biogenesis

Fig. S6. Endogenous SUMO1 modification of KHSRP in clinical cancers. Tumors (T) and paracancerous tissues (P) of gastric cancer (GC) and colorectal cancer (CRC) were lysed in NEM-RIPA buffer and then the proteins were immunoprecipitated by anti-SUMO1 antibody and Western-blotting with indicated antibodies (PDF 458 kb)